These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11793430)

  • 1. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.
    Ross RS; Viazov SO; Hoffmann S; Roggendorf M
    J Clin Lab Anal; 2001; 15(6):308-13. PubMed ID: 11793430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
    Comanor L; Elkin C; Leung K; Krajden M; Kronquist K; Nicolas K; Horansky E; deMedina M; Kittichai P; Sablon E; Ziermann R; Sherlock C
    J Clin Virol; 2003 Sep; 28(1):14-26. PubMed ID: 12927747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
    Hofmann WP; Dries V; Herrmann E; Gärtner B; Zeuzem S; Sarrazin C
    J Clin Virol; 2005 Apr; 32(4):289-93. PubMed ID: 15780807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay.
    Krajden M; Ziermann R; Khan A; Mak A; Leung K; Hendricks D; Comanor L
    J Clin Microbiol; 2002 Aug; 40(8):2903-7. PubMed ID: 12149349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.
    Sarrazin C; Hendricks DA; Sedarati F; Zeuzem S
    J Clin Microbiol; 2001 Aug; 39(8):2850-5. PubMed ID: 11474002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.
    Ferraro D; Giglio M; Bonura C; Di Marco V; Mondelli MU; Craxì A; Di Stefano R
    J Viral Hepat; 2008 Jan; 15(1):66-70. PubMed ID: 18088247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification.
    Gorrin G; Friesenhahn M; Lin P; Sanders M; Pollner R; Eguchi B; Pham J; Roma G; Spidle J; Nicol S; Wong C; Bhade S; Comanor L
    J Clin Microbiol; 2003 Jan; 41(1):310-7. PubMed ID: 12517866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription-mediated amplification linked to line probe assay as a routine tool for HCV typing in clinical laboratories.
    Ross RS; Viazov S; Kpakiwa SS; Roggendorf M
    J Clin Lab Anal; 2007; 21(5):340-7. PubMed ID: 17847116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HCV genotypes 1b and 2a by a reverse transcription loop-mediated isothermal amplification assay.
    Zhao N; Liu J; Sun D
    J Med Virol; 2017 Jun; 89(6):1048-1054. PubMed ID: 27935066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent.
    Forman MS; Valsamakis A
    J Mol Diagn; 2008 Mar; 10(2):147-53. PubMed ID: 18276771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the invader assay for genotyping hepatitis C virus.
    Germer JJ; Majewski DW; Yung B; Mitchell PS; Yao JD
    J Clin Microbiol; 2006 Feb; 44(2):318-23. PubMed ID: 16455877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of HCV RNA with the microwell plate and COBAS Amplicor HCV Monitor assays.
    Arens M
    J Clin Virol; 2003 Aug; 27(3):235-41. PubMed ID: 12878086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification.
    Linnen JM; Gilker JM; Menez A; Vaughn A; Broulik A; Dockter J; Gillotte-Taylor K; Greenbaum K; Kolk DP; Mimms LT; Giachetti C
    J Virol Methods; 2002 Apr; 102(1-2):139-55. PubMed ID: 11879702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
    Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
    Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
    Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
    Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the MagNA pure LC instrument for extraction of hepatitis C virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, version 2.0.
    Germer JJ; Lins MM; Jensen ME; Harmsen WS; Ilstrup DM; Mitchell PS; Cockerill FR; Patel R
    J Clin Microbiol; 2003 Aug; 41(8):3503-8. PubMed ID: 12904346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the quantitative HCV NASBA assay.
    Damen M; Sillekens P; Cuypers HT; Frantzen I; Melsert R
    J Virol Methods; 1999 Sep; 82(1):45-54. PubMed ID: 10507412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.